Joel M. Gelfand
Joel M. Gelfand publishes mostly in Immunology, Rheumatology and Dermatology, on topics such as Psoriasis: Treatment and Pathogenesis, Spondyloarthritis Studies and Treatments and Dermatology and Skin Diseases.
- World rank
- #42,830 of 7,710,434 ranked researchers
- Rank in United States
- #16,472 of 1,627,098
- Works
- 514
- Citations
- 36k
- Citations per work
- 70.2
What does Joel M. Gelfand research?
Joel M. Gelfand's work is mostly in Medicine (38%), Immunology and Microbiology (25%), Economics, Econometrics and Finance (4%).
Their six largest subfields, inside their fields and domains; the grey slice is everything else they publish. The interactive view splits every one of their works down to single topics.
The fields and subfields, with their numbers
- Health Sciences19337.6%
- Medicine19337.6%
- Everything else17634.3%
- Life Sciences12624.6%
- Immunology and Microbiology12624.6%
- Social Sciences183.5%
- 1Immunology25% of their works
- 2Rheumatology16% of their works
- 3Dermatology15% of their works
- 4Physiology4% of their works
- 5Epidemiology4% of their works
- 6Economics and Econometrics4% of their works
Research topics
- Psoriasis: Treatment and Pathogenesis
- Spondyloarthritis Studies and Treatments
- Dermatology and Skin Diseases
- Rheumatoid Arthritis Research and Therapies
- Health Systems, Economic Evaluations, Quality of Life
- Asthma and respiratory diseases
- Cutaneous lymphoproliferative disorders research
- Allergic Rhinitis and Sensitization
Which keywords describe Joel M. Gelfand's research?
The keywords of their largest research topics: IL-17, TH17 Cells, Ankylosing Spondylitis, Spondyloarthritis, Filaggrin, Skin Microbiome, Inflammation and Quality of Life.
- Pollen Allergy
- Cutaneous Lymphomas
- Eosinophils
- Health Utility Measures
- Rheumatoid Arthritis
- Epidemiology
- Quality of Life
- Skin Microbiome
- Spondyloarthritis
- TH17 Cells
- IL-17
- Ankylosing Spondylitis
- Filaggrin
- Inflammation
- Asthma
- Biological Therapy
- Cost-effectiveness Analysis
- Allergic Diseases
- Allergen-specific Immunotherapy
- Mycosis Fungoides
Size is their works in the topics tagged with each word, from their 8 largest topics. Each links to the topic it comes from most. The words come from the keyword list OpenAlex gives each topic, not from the text of the papers, so a word can appear that none of the papers uses.
All 20 words, with their numbers
- IL-172911 topic
- TH17 Cells2911 topic
- Ankylosing Spondylitis1241 topic
- Spondyloarthritis1241 topic
- Filaggrin1231 topic
- Skin Microbiome1231 topic
- Inflammation952 topics
- Quality of Life672 topics
- Asthma602 topics
- Epidemiology602 topics
- Biological Therapy561 topic
- Rheumatoid Arthritis561 topic
- Cost-effectiveness Analysis461 topic
- Health Utility Measures461 topic
- Allergic Diseases391 topic
- Eosinophils391 topic
- Allergen-specific Immunotherapy211 topic
- Cutaneous Lymphomas211 topic
- Mycosis Fungoides211 topic
- Pollen Allergy211 topic
Where does Joel M. Gelfand work?
Joel M. Gelfand's main affiliation in the publication record is University of Pennsylvania, United States.
How many publications and citations does Joel M. Gelfand have?
OpenAlex counts 514 works and 36,067 citations for Joel M. Gelfand, an h-index of 98, ranking #42,830 of 7,710,434 researchers worldwide on the quality score.
Ranked on field-normalised citation excellence (50%), output (30%) and citations (20%). Counts come from OpenAlex author records, which occasionally merge different people who share a name or split one person into several.
Papers, co-authors, who cited this work and researchers on the nearest topics have tabs of their own, above. Is this your page? Claim it with your ORCID iD, or request a correction or removal.
Discussion
Ask a question or share a note about Joel M. Gelfand. Keep it to the research: no personal attacks, advertising or links. Any reader can report a post, which collapses it for everyone until it is opened.